Details for New Drug Application (NDA): 200221
✉ Email this page to a colleague
The generic ingredient in OLANZAPINE is fluoxetine hydrochloride; olanzapine. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride; olanzapine profile page.
Summary for 200221
Tradename: | OLANZAPINE |
Applicant: | Jubilant Generics |
Ingredient: | olanzapine |
Patents: | 0 |
Suppliers and Packaging for NDA: 200221
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 200221 | ANDA | A-S Medication Solutions | 50090-6111 | 50090-6111-0 | 28 BLISTER PACK in 1 CARTON (50090-6111-0) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 200221 | ANDA | Jubilant Cadista Pharmacuticals Inc. | 59746-306 | 59746-306-32 | 3 BLISTER PACK in 1 CARTON (59746-306-32) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (59746-306-12) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 5MG | ||||
Approval Date: | Sep 12, 2012 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 10MG | ||||
Approval Date: | Sep 12, 2012 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 15MG | ||||
Approval Date: | Sep 12, 2012 | TE: | AB | RLD: | No |
Complete Access Available with Subscription